A Practical Approach to Early-Phase CMC
February 20, 2026
Integrated, risk-based chemistry, manufacturing and controls strategies support early-phase development, writes Richard Chubb
6 min read
False
Advertisement
Technology & Manufacturing
A Simpler, Smarter CHO Strategy for High-Quality Bispecifics
By Yiting Lim
February 19, 2026
Here’s how next-generation cell line and manufacturing methods can boost productivity, improve purity, and remove bottlenecks in bispecific antibody development
12 min read
Scaling Smarter: How Continuous Manufacturing Is Reshaping Drug Development
February 13, 2026
Twin-screw extrusion’s role in enabling precise, scalable pharmaceutical manufacturing
7 min read
Bracco Targets Cell Therapy Manufacturing with Bead-Free Microbubble Cell Processing
February 13, 2026
Bead-free microbubble approach aims to simplify cell selection and activation for scalable cell therapy manufacturing
2 min read
New Collaboration to Automate Cell Therapy Manufacturing with Robotics
February 12, 2026
Focus on scaling cell therapy manufacturing using GMP-ready end-to-end robotic biomanufacturing technology
1 min read
Solving the Problem of Insolubility: Part I
February 11, 2026
As drug discovery unlocks harder, more powerful molecules, solubility has become the bottleneck. The first of a three-part series discusses the roots of the problem
5 min read
Beckman Coulter and Automata in Agentic AI Partnership
February 5, 2026
Collaboration will bring next generation orchestration and modular automation to scientists worldwide
1 min read
Overcoming the Challenges of AI Antibody Analysis
By Ben Holland
February 4, 2026
Cracking the molecular code
5 min read
First 20mL Universal Plunger for Large-Volume On-Body Delivery
February 2, 2026
Plunger for 20mL cartridges aims to meet rising demand for on-body delivery of higher dose therapies
1 min read
Oral GLP-1s Won’t Win on Convenience – They’ll Win on CMC
By Achim Link
January 28, 2026
GLP-1 peptides validated the science. CMC will validate the small molecule modality for GLP-1 efficacy, scalability, and access.
4 min read
